Tempus AI, a precision medicine-based technology company, has announced the beta launch of its new personal health concierge app, olivia.
olivia is an artificial intelligence (AI)-based app designed to empower users to comprehensively organise, manage, and take charge of their health data.
Currently, olivia is available only to beta testers. This app uses generative AI to deliver personalised, concierge-level health support for managing health.
olivia offers tools to consolidate your health information, track symptoms, and prepare for doctor’s appointments. All features are integrated into one easy-to-use platform.
The app aims to equip everyone with the tools and information needed to receive the best possible treatment.
It addresses the growing complexity of clinical care, ensuring users can navigate their health journey effectively.
olivia’s suite of features includes seamless connection with providers, allowing users to aggregate health records by directly connecting with healthcare institutions.
This feature facilitates the upload, organisation, and management of clinical data, scans, slides, molecular tests, and more in one convenient location.
The app also offers a comprehensive patient profile that consolidates and structures health data, enabling users to download and share this information with clinicians easily.
For appointment preparation, olivia helps users compile relevant health data, documents, and key questions to ensure productive conversations with healthcare providers.
Additionally, the health concierge app supports health monitoring by tracking symptoms, sleep, and diet, highlighting key trends, and creating a detailed health journal.
Tempus AI CEO and founder Eric Lefkofsky said: “olivia leverages the enormous investments we have made on behalf of physicians to help patients aggregate multimodal healthcare data at scale and use AI to derive real time insights.
“As AI becomes more pervasive, individuals are going to need tools like olivia to ensure they are getting the very best care for themselves and their loved ones.”
Recently, the technology company signed a multi-year deal with BioNTech for real-world data collaboration.
Through this collaboration, Tempus AI is offering its analytical support and computational biology expertise to BioNTech for its oncology research and development pipeline.
BioNTech will work with Tempus AI to utilise its real-world multimodal database, generating novel insights into biological mechanisms.
